Identification of N6-methylandenosine related lncRNA signatures for predicting the prognosis and therapy response in colorectal cancer patients

Despite recent advances in surgical and multimodal therapies, the overall survival (OS) of advanced colorectal cancer (CRC) patients remains low. Thus, discerning sensitive prognostic biomarkers to give the optimistic treatment for CRC patients is extremely critical. N6-methyladenosine (m6A) and lon...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhiyong, Liu, Yang, Yi, Huijie, Cai, Ting, Wei, Yunwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561883/
https://www.ncbi.nlm.nih.gov/pubmed/36246627
http://dx.doi.org/10.3389/fgene.2022.947747

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561883/
https://www.ncbi.nlm.nih.gov/pubmed/36246627
http://dx.doi.org/10.3389/fgene.2022.947747

Ejemplares similares